Work

Histone deacetylase inhibition overcomes rapamycin resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling via mTORC2 - Evidence review

Year: 2026
Type: article
Abstract: In diffuse large B-cell lymphoma, cell and tumor studies show rapamycin can trigger AKT activation via mTORC2; HDAC inhibition may counter this response.
Language: English
Open Access status: green
OpenAlex ID: W7236600366
FWCI:
Cites:
Cited by:
Related to: 10